Patent · US Active

Use of a DPP-4 inhibitor in SIRS and/or sepsis

US12312352B2 · kind B2 · utility

0Cited by

165References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thomas KLEIN · Radolfzell, DE
Andreas DAIBER · Scheeßel, DE
Klaus Dugi · Dresden, DE
Michael Mark · Biberach an der Riß, DE
Thomas MUENZEL · Mainz, DE

Key dates

Filing date	Apr 27, 2022
Grant date	May 27, 2025
Priority date	—
Expiry date	Apr 27, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for treating and/or preventing SIRS and/or sepsis comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of SIRS and/or sepsis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.